Physiological NF-κB response is normally transient and is characterized by the efficient termination of NF-κB activity by a number of signalling mechanisms3; however, in many pathological situations, such as chronic inflammation and some cancers, NF-κB activity becomes excessive and/or persistent, contributing to the development of disease4,5. Here, NFKB1 is linked to cancer.